Clinical Trial Update: A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

View source ↗

Summary

A retrospective study assessing safety and efficacy of combining locoregional therapies with anti-VEGF/TKIs and immune checkpoint inhibitors in hepatocellular c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Ningbo Medical Center Lihuili Hospital | Conditions: Hepatocellular Carcinoma, Liver Transplantation | Status: NOT_YET_RECRUITING